Military Psychiatry section of HPA, Κλάδος Στρατιωτικής Ψυχιατρικής ΕΨΕ

08/09/2025

Aug 2025 Message from the WFMH President Tsuyoshi AkiyamaWFMH President Dear Friends in the World The theme of this year’s World Mental Health Day is “Access to Services – Mental Health in Catastrophes and Emergencies.” This theme seems highly opportune to the current global situation. The w...

05/09/2025

PSYCHIATRIC NEWS ALERT | Developed by a multidisciplinary workgroup, the new guideline is intended for use by any clinician who may encounter delirium in their scope of practice. https://ow.ly/m0in50WQ7ug

30/08/2025

SAMHSA’s Awareness Month Toolkit is now available
🆕 Access ready-to-use social media copy and graphics, resources, and actionable steps to help you make a difference in your community ➡️ samhsa.gov/about/digital-toolkits/suicide-prevention-month

28/08/2025

The entire August issue of Psychiatric Times—exploring the management obesity and metabolic dysfunction in schizophrenia, issues in diversity, spirituality and psychiatry, and more—is now live on our website. Read it here: https://www.psychiatrictimes.com/journals/psychiatric-times/vol-42-issue-8

28/08/2025

27/08/2025

Climate change and related disasters cause anxiety-related responses as well as chronic and severe mental health disorders. Flooding and prolonged droughts h...

25/08/2025

Leqembi for the treatment of Alzheimer disease has been launched in Austria on August 25, 2025, and will be launched in Germany on September 1, 2025—the first launches in the EU.

22/08/2025

Antidepressant treatment for late-life depression enhances cognitive functions like memory and learning, linking symptom relief to cognitive improvement.

18/08/2025

With the theme of this year’s APA Annual Meeting being all about lifestyle for mental and physical health – we wanted to hear how psychiatrists are keeping h...

14/08/2025

In a real-world study of 20,000+ patients with major depressive disorder, pharmacogenomic testing was linked to a 39% reduction in prescribing of medications with significant gene-drug interactions and fewer psychiatric hospitalizations and ED visits. These findings highlight the potential of PGx-guided care to improve outcomes and reduce healthcare burden. Read more: https://journals.lww.com/psychopharmacology/fulltext/2025/07000/real_world_impact_of_pharmacogenomic_testing_on.3.aspx